Nature Communications (Jun 2021)

Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance

  • Haohao Huang,
  • Songyang Zhang,
  • Yuanyuan Li,
  • Zhaodan Liu,
  • Lanjuan Mi,
  • Yan Cai,
  • Xinzheng Wang,
  • Lishu Chen,
  • Haowen Ran,
  • Dake Xiao,
  • Fangye Li,
  • Jiaqi Wu,
  • Tingting Li,
  • Qiuying Han,
  • Liang Chen,
  • Xin Pan,
  • Huiyan Li,
  • Tao Li,
  • Kun He,
  • Ailing Li,
  • Xuemin Zhang,
  • Tao Zhou,
  • Qing Xia,
  • Jianghong Man

DOI
https://doi.org/10.1038/s41467-021-24108-6
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 16

Abstract

Read online

How ROS levels are regulated in cancer stem cells and their contribution to cancer resistance is currently not clear. Here, the authors show that prohibitin regulates mitochondrial ROS production stabilizing the peroxidase PRDX3 and this accounts for radiotherapy resistance in glioma stem-like cells.